Brian is an Assistant Professor of Chemistry and Chemical Biology at Harvard University. He obtained his bachelor’s degree in Chemistry and Physics from Harvard College and a PhD in Chemistry from Harvard University. During his PhD studies, Brian completed the chemical synthesis of complex bioactive natural products and investigated their biological mechanism of action. As a postdoctoral fellow at Massachusetts General Hospital, he studied epigenomic mechanisms of adaptation and drug resistance in brain cancer. Currently, his research group is pioneering new approaches that combine chemical biology with genomic technologies to investigate mechanisms in chromatin and cancer biology. Brian is also an Associate Member of the Broad Institute and a recipient of the Ono Pharma Breakthrough Science Initiative Award, the NIH Director’s New Innovator Award, and the Damon Runyon-Rachleff Innovation Award.